1001409-50-2 | PDK1 inhibitor

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	1 week	$50.00	$35.00
5mg	95%	1 week	$121.00	$85.00
50mg	95%	1 week	$1,108.00	$775.00
100mg	95%	1 week	$1,765.00	$1,235.00

Description

• Catalog Number: AE11310
• Chemical Name: PDK1 inhibitor
• CAS Number: 1001409-50-2
• Molecular Formula: C28H22F2N4O4
• Molecular Weight: 516.4954863999999
• MDL Number: MFCD18642668
• SMILES: O=C(c1cccn(c1=O)Cc1ccc(c(c1)F)F)N[C@H](c1ccccc1)COc1ccc2c(c1)[nH]c(=O)[nH]2

Upstream Synthesis Route

PDK1 inhibitor is a valuable tool in chemical synthesis, particularly in the field of drug discovery and development. By specifically targeting and inhibiting the enzyme PDK1 (3-phosphoinositide-dependent protein kinase 1), this inhibitor can modulate key signaling pathways involved in cellular processes such as proliferation, differentiation, and survival.In chemical synthesis, PDK1 inhibitor plays a crucial role in the design and optimization of novel pharmaceutical compounds. By blocking the activity of PDK1, researchers can gain insights into the intricate mechanisms of various diseases, such as cancer and diabetes, and develop potent inhibitors with therapeutic potential. Additionally, PDK1 inhibitor can help in elucidating the role of specific signaling cascades and pathways, allowing for the identification of new drug targets and the development of more effective treatments.Furthermore, the application of PDK1 inhibitor in chemical synthesis enables the investigation of protein-protein interactions, protein phosphorylation events, and other molecular processes that are vital for understanding disease pathways. This inhibitor can also be utilized in screening assays and high-throughput drug discovery approaches to identify lead compounds with promising pharmacological profiles.Overall, the use of PDK1 inhibitor in chemical synthesis offers a powerful strategy for advancing drug discovery efforts, uncovering disease mechanisms, and ultimately improving human health.